Drug development
Being well and healthy comes near the top of most people’s wish list. If we fall ill, the body can sometimes heal itself, but we generally need the help of medicines – temporarily or in some cases all our life. Medical advances increase our chances of recovering. Pharmaceutical research at Uppsala University focuses on preventing, treating, relieving and ultimately perhaps curing diseases and developing new therapies that help people to survive sickness and live life to the full.
Uppsala University has Sweden’s only faculty of pharmacy. It mobilises all the skills needed to develop a pharmaceutical product from laboratory to clinical therapy: from basic studies of how specific substances can be developed into drugs, to how they affect the cells of the body and how they benefit society. The three departments are devoted to research on medicinal chemistry, pharmacy and pharmaceutical biosciences, and have expertise in drug development, medical imaging, genetics and bioinformatics – with global benefits in healthcare and industry.
Examples of ongoing research
Now comes the tools with the potential to revolutionise cancer research
With the upcoming launches of his award winning method to analyse protein activity in cells and a ne...
New biomarkers can lead to breakthrough in diabetes research
With the discovery of two new biomarkers, Olof Eriksson, researcher in translational imaging, may le...
Björn Wettermark creates tools for optimised drug utilisation
The path of the drug from laboratory to patient is long and every year non-optimised medication use ...
Research centres and infrastructures
Swedish Drug Delivery Centre (SweDeliver)
The Swedish Drug Delivery Centre (SweDeliver) is a world-leading research and competence centre in drug delivery. SweDeliver focuses on research in parenteral, oral and pulmonary drug delivery. This research is designed to result in the development of new and improved pharmaceutical therapies, taking both outcomes and patient safety into account. SweDeliver also aims to reinforce the strong research environment and ecosystem surrounding the field of drug delivery in the Nordic countries.
Swedish Drug Delivery Centre (SweDeliver)
Drug Discovery and Development Platform (DDD)
The Drug Discovery and Development Platform (DDD) is a national SciLifeLab facility for drug development. The facility has the infrastructure needed to discover and produce new therapeutic concepts and drug prototypes for small molecules and antibodies.
Drug Discovery and Development Platform (DDD)
Genome Medicine Centre in Uppsala (GMC Uppsala)
The Genomic Medicine Centre in Uppsala (GMC Uppsala) aims to serve as a catalyst for the transfer of research findings to clinical diagnostics. The centre collaborates closely with the SciLifeLab facility Clinical Genomics Uppsala, which develops diagnostics for cancer and hereditary diseases.
Genomic Medicine Centre in Uppsala (GMC Uppsala)
Clinical Genomics Uppsala
Clinical Genomics Uppsala is a national facility specialising in translational research and development of tests for genetic diagnostics. Using the latest sequencing methods and advanced bioinformatics, Clinical Genomics Uppsala develops and provides clinical genetic tests for various forms of cancer and hereditary diseases.
European Infrastructure for Translational Medicine (EATRIS)
Uppsala hosts the Swedish Coordination Centre for EATRIS, the European Infrastructure for Translational Medicine. EATRIS pursues research in cellular and genetic therapy, biomarkers, imaging and tracing, small molecules and vaccines.
European Infrastructure for Translational Medicin (EATRIS)
Testa Center
The Testa Center laboratory is a testbed for scaling up biological processes for the production of monoclonal antibodies, peptides, proteins, vaccines, viral vectors, etc.